BITETTO, Davide
 Distribuzione geografica
Continente #
NA - Nord America 1.299
EU - Europa 284
AS - Asia 81
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.667
Nazione #
US - Stati Uniti d'America 1.292
UA - Ucraina 84
CN - Cina 45
SE - Svezia 45
DE - Germania 42
IT - Italia 32
IE - Irlanda 21
GB - Regno Unito 18
TR - Turchia 16
FR - Francia 15
IR - Iran 13
FI - Finlandia 10
BE - Belgio 8
CA - Canada 7
VN - Vietnam 5
IN - India 2
PL - Polonia 2
RU - Federazione Russa 2
AT - Austria 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
NO - Norvegia 1
TG - Togo 1
Totale 1.667
Città #
Fairfield 188
Chandler 186
Woodbridge 123
Seattle 76
Houston 75
Ashburn 67
Ann Arbor 65
Wilmington 62
Jacksonville 54
Cambridge 53
Dearborn 45
Princeton 22
Dublin 21
Beijing 18
Udine 17
Izmir 14
San Diego 14
Leawood 11
Los Angeles 10
Falls Church 9
Boardman 8
Brussels 8
Trieste 8
Zanjan 8
Norwalk 7
Des Moines 5
Dong Ket 5
Fuzhou 4
Kunming 4
Ottawa 4
Ardabil 3
Augusta 3
Ogden 3
San Mateo 3
Zhengzhou 3
Acworth 2
Guangzhou 2
Henderson 2
Huzhou 2
Monmouth Junction 2
Nanjing 2
New York 2
Toronto 2
Warsaw 2
Washington 2
Andover 1
Bassano Del Grappa 1
Castenedolo 1
Chengdu 1
Chongqing 1
Edinburgh 1
Grafing 1
Hefei 1
Lomé 1
Lyon 1
Nanchang 1
Nanning 1
Oslo 1
Pamplona 1
Paris 1
Phoenix 1
Prague 1
Vancouver 1
Vienna 1
Wuhan 1
Zurich 1
Totale 1.247
Nome #
Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. 177
Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C. 135
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome. 117
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C. 115
Biliary strictures after liver transplantation: Role of interleukin 28B genotypes in cyclosporine treated 109
Clinical and virologic response to entecavir in HBV related chronic hepatitis or cirrhosis: data from the clinical practice in a single centre cohort. 107
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E e4 carriers: relationship with the blood lipid profile 99
GENE POLYMORPHISM AT THE INTERLEUKIN 6 -174 G > C LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 97
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 96
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used. 93
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. 92
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. 91
INFLUENCE OF ANGIOTENSIN-CONVERTING ENZYME I/D GENE POLYMORPHISM ON CLINICAL AND HISTOLOGICAL CORRELATES OF CHRONIC HEPATITIS C 88
Vitamin D and the risk of acute allograft rejection following human liver transplantation. 80
Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis 39
Challenges and future developments in liver transplantation 31
Recurrent and treatment-unresponsive spontaneous bacterial peritonitis worsens survival in decompensated liver cirrhosis 31
New organ allocation criteria in liver transplantation 28
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency 23
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study 22
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 20
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: Implications for clinical management 19
Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients 14
Totale 1.723
Categoria #
all - tutte 5.787
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.787


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 0 0 0 0 0 0 0 0 0 38
2019/2020489 31 20 19 78 44 72 64 53 40 38 3 27
2020/2021329 5 27 37 55 10 33 15 27 30 14 53 23
2021/2022204 8 11 14 12 3 10 14 3 9 24 71 25
2022/2023336 27 47 1 61 29 81 0 22 54 2 5 7
2023/202474 16 10 14 0 7 10 0 2 4 11 0 0
Totale 1.723